These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 22361334)

  • 1. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.
    Takahashi H; Numasaki M; Lotze MT; Sasaki H
    Immunol Lett; 2005 May; 98(2):189-93. PubMed ID: 15860217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
    Yamada M; Kim S; Egashira K; Takeya M; Ikeda T; Mimura O; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1996-2001. PubMed ID: 14500291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network--a future therapy for ischemically challenged tissue.
    Spanholtz TA; Theodorou P; Holzbach T; Wutzler S; Giunta RE; Machens HG
    J Surg Res; 2011 Nov; 171(1):329-38. PubMed ID: 20605609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol Promotes Angiogenesis and Increases Cell Proliferation After Myocardial Ischemia-Reperfusion Injury Through a cAMP-Dependent Mechanism.
    Li J; Xiang X; Xu H; Shi Y
    Cardiovasc Eng Technol; 2019 Dec; 10(4):638-647. PubMed ID: 31625080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey.
    Wei P; Yu FQ; Chen XL; Tao SX; Han CS; Liu YX
    Placenta; 2004; 25(2-3):184-96. PubMed ID: 14972451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.
    Okada M; Matsumori A; Ono K; Miyamoto T; Takahashi M; Sasayama S
    Biochem Biophys Res Commun; 1999 Feb; 255(1):80-7. PubMed ID: 10082659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
    J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
    Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA
    Exp Eye Res; 2009 Jan; 88(1):79-91. PubMed ID: 19013152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
    Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
    Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
    Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
    Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation.
    Zhu G; Huang L; Song M; Yu Z; Wu X; Zhao X; Jin J; Zhao G; Chen J; Yu S
    Int J Cardiol; 2010 Jan; 138(1):70-80. PubMed ID: 19095317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.